New Delhi, Feb. 7 -- Alkem Laboratories Ltd has announced the acquisition of Adroit Biomed, a dermatology and cosmetology-focused company, and Bombay Ortho Industries, a medical technology firm, in two separate deals. The acquisitions will strengthen Alkem's presence in high-growth therapeutic segments and enhance its manufacturing capabilities in the orthopedic implant space.

Alkem will acquire Adroit Biomed for Rs.140 crore, payable in two tranches, with the transaction expected to close by 1 April. Adroit, which reported a turnover of Rs.53.55 crore in FY24, will help Alkem expand its dermatology and cosmetology portfolio, market reach, and omni-channel presence.

Read this | Piramal Pharma to expand injectables portfolio in complex h...